We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Open Drawer MenuClose Drawer Menu
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Collaborative Study: chronic fatigue syndrome – Research Report

Identifying illness parameters in fatiguing syndromes using classical projection methods

    Published Online:12 Apr 2006https://doi.org/10.2217/14622416.7.3.407

    Abstract

    Objectives: To examine the potential of multivariate projection methods in identifying common patterns of change in clinical and gene expression data that capture the illness state of subjects with unexplained fatigue and nonfatigued control participants. Methods: Data for 111 female subjects was examined. A total of 59 indicators, including multidimensional fatigue inventory (MFI), medical outcome Short Form 36 (SF-36), Centers for Disease Control and Prevention (CDC) symptom inventory and cognitive response described illness. Partial least squares (PLS) was used to construct two feature spaces: one describing the symptom space from gene expression in peripheral blood mononuclear cells (PBMC) and one based on 117 clinical variables. Multiplicative scatter correction followed by quantile normalization was applied for trend removal and range adjustment of microarray data. Microarray quality was assessed using mean Pearson correlation between samples. Benjamini-Hochberg multiple testing criteria served to identify significantly expressed probes. Results: A single common trend in 59 symptom constructs isolates of nonfatigued subjects from the overall group. This segregation is supported by two co-regulation patterns representing 10% of the overall microarray variation. Of the 39 principal contributors, the 17 probes annotated related to basic cellular processes involved in cell signaling, ion transport and immune system function. The single most influential gene was sestrin 1 (SESN1), supporting recent evidence of oxidative stress involvement in chronic fatigue syndrome (CFS). Dominant variables in the clinical feature space described heart rate variability (HRV) during sleep. Potassium and free thyroxine (T4) also figure prominently. Conclusion: Combining multiple symptom, gene or clinical variables into composite features provides better discrimination of the illness state than even the most influential variable used alone. Although the exact mechanism is unclear, results suggest a common link between oxidative stress, immune system dysfunction and potassium imbalance in CFS patients leading to impaired sympatho-vagal balance strongly reflected in abnormal HRV.

    Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.

    Bibliography

    • 1  Evengard B, Evengard B, Schacterle RS, Komaroff AL: Chronic fatigue syndrome: new insights and old ignorance. J. Intern. Med. 246, 455–469 (1999).
      MedlineGoogle Scholar
    • 2  Lyall M, Peakman M, Wessely S: A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J. Psychosom. Res.55, 79–90 (2003).
      MedlineGoogle Scholar
    • 3  Papanicolaou DA, Amsterdam JD, Levine S et al.: Neuroendocrine aspects of chronic fatigue syndrome. Neuroimmunomodulation11, 65–74 (2004).
      Medline CASGoogle Scholar
    • 4  Moss-Morris R, Petrie KJ: Discriminating between chronic fatigue syndrome and depression: a cognitive analysis. Psychol. Med.31, 469–479 (2001).
      Medline CASGoogle Scholar
    • 5  Pheley AM, Melby D, Schenck C, Mandel J, Peterson JK: Can we predict recovery in chronic fatigue syndrome? Minn. Med.82, 52–56 (1999).
      Medline CASGoogle Scholar
    • 6  Reyes M, Dobbin JG, Nisenbaum R, Subedar N, Randall B, Reeves WC: Chronic fatigue syndrome progression and self-defined recovery: evidence from CDC surveillance system. J. Chronic Fatigue Syndr.5, 17–27 (1999).
      Google Scholar
    • 7  Vernon SD, Reeves WC: The challenge of integrating disparate high-content data: epidemiologic, clinical, and laboratory data collected during an in-hospital study of chronic fatigue syndrome. Pharmacogenomics7(3), 345–354 (2006).
      Google Scholar
    • 8  Vernon SD, Unger ER, Dimulescu IM, Rajeevan M, Reeves WC: Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis. Markers18, 193–199 (2002).• This is one of the pioneering studies that demonstrated the successful use of gene expression measurements from peripheral blood mononuclear cells (PBMCs) in the study of chronic fatigue syndrome (CFS). This study also points to immune system activation in CFS patients, as do the results herein.
      Medline CASGoogle Scholar
    • 9  Whistler T, Jones JF, Unger ER, Vernon SD: Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol.5, 5 (2005).• This work again demonstrates the use of gene expression in PBMCs using a larger array of probes. More importantly, study results show a set of gene ontology categories that align well with gene functional groups found to distinguish CFS from nonfatigued subjects in this work.
      MedlineGoogle Scholar
    • 10  Reeves WC, Wagner D, Nisenbaum R et al.: Chronic fatigue syndrome – a clinically empirical approach to its definition and study. BMC Med.3, 19 (2005).
      MedlineGoogle Scholar
    • 11  Wagner D, Nisenbaum R, Heim C, Jones JF, Unger ER, Reeves WC: Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul. Health Metr.3, 8 (2005).
      MedlineGoogle Scholar
    • 12  Martens H, Naes T: Multiplicative signal correction (MSC). In: Multivariate Calibration. John Wiley and Sons Ltd, New York, NY, USA, 345–351 (1991).
      Google Scholar
    • 13  Geladi P, MacDougall D, Martens H: Linearization and scatter correction for near-infrared reflectance spectra of meat. Appl. Spectroscopy39, 491–500 (1985).
      Google Scholar
    • 14  Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics19, 185–193 (2003).
      Medline CASGoogle Scholar
    • 15  Park T, Yi S-G, Lee SY, Lee JK: Diagnostic plots for detecting outlying slides in a cDNA microarray experiment. BioTechniques38, 463–471 (2005).
      Medline CASGoogle Scholar
    • 16  Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B57(1), 289–300 (1995).
      Google Scholar
    • 17  Wold H: Estimation of principal components and related models by iterative least squares. In: Multivariate Analysis. Krishnaiah PR, (Ed.), Academic Press, New York, NY, USA, 391–420 (1966).
      Google Scholar
    • 18  Efron B, Gong G: A leisurely look at the bootstrap, the jackknife, and cross-validation. Amer. Statist.37, 36–48 (1983).
      Google Scholar
    • 19  Krzanowski WJ: Cross-validation in principal component analysis. Biometrics43, 575–584 (1987).
      Google Scholar
    • 20  Wold S, Trygg J, Berglund A, Antti H: Some recent developments in PLS modeling. Chemom. Intell. Lab. Syst.58, 131–149 (2001).
      CASGoogle Scholar
    • 21  Whistler T, Craddock RC, Taylor R, Broderick G, Klimas N, Unger ER: Gene expression correlates of fatigue. Pharmacogenomics7(3), 395–405 (2006).
      Google Scholar
    • 22  Jackson JE: A user's guide to principal components. John Wiley and Sons Ltd., New York, NY, USA (1991).
      Google Scholar
    • 23  Kaushik N, Fear D, Richards SCM et al.: Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J. Clin. Pathol.58, 826–832 (2005).• In this work a larger array is used than in [8] and [9]. Furthermore, polymerase chain reaction (PCR) is used to validate microarray results. Once again the functional categories identified align well with results from the present study.
      Medline CASGoogle Scholar
    • 24  Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJF: Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic. Biol. Med.39, 584–589 (2005).•• This presents new and convincing evidence linking CFS to excessive free radical generation. A very thorough review of literature is used to discuss the repercussions and possible causes of this free radical generation. These include possible ties to the gene functions identified in this study such as immune system activation and ion channel activity.
      Medline CASGoogle Scholar
    • 25  Fantone JC, Ward PA: Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease. Hum. Pathol.16, 973–978 (1985).
      Medline CASGoogle Scholar
    • 26  Elliott S J, Koliwad SK: Oxidant stress and endothelial membrane transport. Free Radic. Biol. Med.49, 649– 658 (1995).
      MedlineGoogle Scholar
    • 27  Fletcher J, Buch AN, Routledge HC, Chowdhary S, Coote JH, Townend JN: Acute aldosterone antagonism improves cardiac vagal control in humans. J. Am. Coll. Cardiol.43(7), 1270–1275 (2004).
      Medline CASGoogle Scholar
    • 28  Levite M, Cahalon L, Peretz A et al.: Extracellular K+ and opening of voltage-gated potassium channels activate T-cell integrin function: physical and functional association between Kv1.3 channels and β1 integrins. J. Exp. Med.191, 1167–1176 (2000).
      Medline CASGoogle Scholar
    • 29  Nijs J, Demanet C, McGregor NR et al.: Monitoring a hypothetical channelopathy in chronic fatigue syndrome: preliminary observations. J. Chronic Fatigue Syndr.11(1), 117–133 (2003).
      Google Scholar
    • 30  Jones JF, Nisenbaum R, Reeves WC: Medication use by persons with chronic fatigue syndrome: results of a randomized telephone survey in Wichita, Kansas. Health Qual. Life Outcomes1, 74 (2003).•• This work addresses the quintessential challenge that medication use presents to CFS studies. Of particular interest is the fact that study results fail to find a correlation between CFS remission and medication use. This supports the hypothesis that the medications in question do not significantly alter CFS pathophysiology.
      Google Scholar
    • 101  BioRag (Bioresource for array genes), Bioinformatics group at Arizona Cancer Center. www.biorag.org
      Google Scholar